Prolonged remission in adult-onset Still's disease with etanercept

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Prolonged remission in adult-onset Still's disease with etanercept

Abstract

References

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.

Adult-onset Still's disease. Clinical course and outcome

Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France

Adult onset Still's disease in northern India: comparison with juvenile onset Still's disease

Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept

Etanercept in the treatment of adult patients with Still's disease

Adult onset Still's disease: response to Enbrel

Infliximab in a case of early adult-onset Still's disease

Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients

Longterm outcome of TNF blockade in adult-onset Still's disease

Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases

Citations

Biologic treatments for adult-onset Still's disease

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions

Ten years of clinical experience with adult onset Still's disease: is the outcome improving?

Clinical features and prognosis in adult-onset Still's disease: a study of 104 cases.

Adult-onset Still's disease: a report of 28 cases and review of the literature

Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept

Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options

Biological treatment in adult-onset Still's disease

Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature

Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients

Refractory adult-onset still disease successfully treated with abatacept

Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances.

Steroid-sparing effects of etanercept in a patient with steroid-dependent adult-onset Still's disease

Related Concepts

Related Feeds

Adult-Onset Still's Disease

Related Papers

Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases

Resolution with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease

Infliximab in a case of early adult-onset Still's disease

Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients

Comment on: Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept